Human Calmodulin-Like Protein CALML3: A Novel Marker for Normal Oral Squamous Mucosa That Is Downregulated in Malignant Transformation
Oral cancer is often diagnosed only at advanced stages due to a lack of reliable disease markers. The purpose of this study was to determine if the epithelial-specific human calmodulin-like protein (CALML3) could be used as marker for the various phases of oral tumor progression. Immunohistochemical...
Saved in:
Main Authors: | Michael D. Brooks (Author), Richard D. Bennett (Author), Amy L. Weaver (Author), Thomas J. Sebo (Author), Steven E. Eckert (Author), Emanuel E. Strehler (Author), Alan B. Carr (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Calmodulin Mutations in Human Disease
by: John W. Hussey, et al.
Published: (2023) -
LncRNA CALML3-AS1 regulates chondrocyte apoptosis by acting as a sponge for miR-146a
by: Tingting Nie, et al.
Published: (2021) -
Study of expression of p63 and Ki-67 in normal, dysplastic, and malignant lesions of oral mucosa
by: Chhaya Rani Shevra, et al.
Published: (2023) -
Plasma Membrane Calcium ATPases as Novel Candidates for Therapeutic Agent Development
by: Emanuel E Strehler
Published: (2013) -
A comparative study on the mast cells count in oral squamous cell carcinoma and normal oral mucosa
by: Mahsa Dastpak, et al.
Published: (2015)